NCT04273165View on ClinicalTrials.gov

Safety and Efficacy of Etravirine in Friedreich Ataxia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

January 17, 2023

Study Completion Date

January 17, 2023

Conditions
Friedreich Ataxia
Interventions
DRUG

Etravirine Tablets

Daily etravirine BID with 100 or 200 tablets for 4 months

Trial Locations (1)

31953

IRCCS Medea Scientific Institute, Pieve di Soligo Research Centre, Pieve di Soligo

All Listed Sponsors
collaborator

University of Rome Tor Vergata

OTHER

lead

IRCCS Eugenio Medea

OTHER

NCT04273165 - Safety and Efficacy of Etravirine in Friedreich Ataxia Patients | Biotech Hunter | Biotech Hunter